EX-32.2 7 ex322.htm EX-32.2 EX-32.2
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Worldwide Biotech and Pharmaceutical Company (the “Company”) on Form 10-KSB for the period ending December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, PEIYI TIAN, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

2.
The information contained in the Report fairly presents, in all materials respects, the financial condition and results of operations of the Company.

     
  Worldwide Biotech and Pharmaceutical Company
 
 
 
 
 
 
Date: April 5, 2006    By:   /s/ Peiyi Tian
 
  Chief Financial Officer